Years Active: 2025
Title: Thomas Edgeworth White: Innovator in Cancer Treatment
Introduction
Thomas Edgeworth White is a notable inventor based in Norwalk, CT (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents for cancer treatment. His innovative work has the potential to impact the lives of many patients battling cancer.
Latest Patents
White holds a patent for "ADAM17 binding molecules and uses thereof." This invention provides various ADAM17 binding molecules, including antibodies and fragments thereof. The patent outlines compositions comprising these binding molecules and methods for their use, such as inhibiting the binding of ADAM17 to its substrates, including ErbB ligands. This technology aims to inhibit the proliferation of cancer cells and offers new avenues for cancer treatment.
Career Highlights
Throughout his career, Thomas Edgeworth White has focused on the intersection of molecular biology and therapeutic development. His work has led to advancements in understanding how specific molecules can be utilized to combat cancer. With a patent portfolio that includes 1 patent, he has established himself as a key figure in the field.
Collaborations
White has collaborated with talented individuals such as Dimitar Nikolov and Nayanendu Saha. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.
Conclusion
Thomas Edgeworth White's contributions to cancer treatment through his patented ADAM17 binding molecules highlight the importance of innovation in biotechnology. His work exemplifies how targeted therapies can lead to significant advancements in medical science.